Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells
Case reports and small trials show noticeable regrowth and nail thickening once levels are corrected
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
M., & Zeisel, S
E., Remme, W
US$ 25.95
US$ 23.91
US$ 24.04
US$ 26.80
US$ 25.82
US$ 27.94
